Canopy Growth (CGC) Receivables (2017 - 2026)
Canopy Growth (CGC) posted Receivables of $23.0 million for Q1 2026, down 5.49% sequentially from $24.3 million in Q4 2025, and down 37.75% YoY from $36.9 million in Q1 2025.
Canopy Growth (CGC) Receivables (2017 - 2026) Analysis & Trends
Canopy Growth has reported Receivables for 10 years, with the latest figure at $23.0 million in Q1 2026.
- Quarterly Receivables fell 37.75% year-over-year to $23.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.0 million (down 37.75% YoY) and the FY2026 annual result came in at $26.7 million, down 27.78% from the prior year.
- Receivables declined to $23.0 million in Q1 2026 per CGC's latest filing, from $24.3 million in the prior quarter.
- Over five years, Receivables peaked at $114.6 million in Q2 2023 and troughed at $18.4 million in Q3 2025.
- A 5-year average of $45.6 million and a median of $36.9 million in 2025 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables surged 66.56% in 2023, then sank 70.47% in 2024.
- Over 5 years, Receivables stood at $62.1 million in 2022, then slipped by 17.49% to $51.2 million in 2023, then tumbled by 30.04% to $35.8 million in 2024, then sank by 32.11% to $24.3 million in 2025, then retreated by 5.49% to $23.0 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $23.0 million, $24.3 million, and $18.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Canopy Growth | 441.18 Mn | 194.17 Mn | 16.08 Mn | 33.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.22 Mn |
| Mar 31, 2026 | 22.99 Mn |
| Dec 31, 2025 | 24.33 Mn |
| Sep 30, 2025 | 18.39 Mn |
| Jun 30, 2025 | 36.34 Mn |
| Mar 31, 2025 | 36.94 Mn |
| Dec 31, 2024 | 35.84 Mn |
| Sep 30, 2024 | 28.51 Mn |
| Jun 30, 2024 | 33.85 Mn |
| Mar 31, 2024 | 41.08 Mn |
| Dec 31, 2023 | 51.22 Mn |
| Sep 30, 2023 | 41.76 Mn |
| Jun 30, 2023 | 114.62 Mn |
| Mar 31, 2023 | 33.48 Mn |
| Dec 31, 2022 | 62.08 Mn |
| Sep 30, 2022 | 66.78 Mn |
| Jun 30, 2022 | 68.82 Mn |
| Mar 31, 2022 | 58.94 Mn |
| Dec 31, 2021 | 70.59 Mn |
| Sep 30, 2021 | 64.04 Mn |